DKNG DraftKings | $45.41 +0.1% | 3/28/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $55.00 | N/A | View details for JPMorgan Chase & Co. rating of DraftKings (NASDAQ:DKNG) on 3/28/2024 |
BRZE Braze | $44.30 -12.4% | 3/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $60.00 -> $58.00 | N/A | View details for JPMorgan Chase & Co. rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
GDS GDS | $6.65 +5.1% | 3/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $12.00 -> $7.00 | N/A | View details for JPMorgan Chase & Co. rating of GDS (NASDAQ:GDS) on 3/28/2024 |
CCL Carnival Co. & | $16.34 -4.9% | 3/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $22.00 -> $23.00 | Low | View details for JPMorgan Chase & Co. rating of Carnival Co. & (NYSE:CCL) on 3/28/2024 |
RH RH | $347.99 +17.2% | 3/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $329.00 -> $345.00 | Low | View details for JPMorgan Chase & Co. rating of RH (NYSE:RH) on 3/28/2024 |
EOG EOG Resources | $127.84 +1.1% | 3/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $134.00 -> $141.00 | Low | View details for JPMorgan Chase & Co. rating of EOG Resources (NYSE:EOG) on 3/28/2024 |
|
AR Antero Resources | $29.00 +1.0% | 3/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $30.00 -> $32.00 | Low | View details for JPMorgan Chase & Co. rating of Antero Resources (NYSE:AR) on 3/27/2024 |
TDG TransDigm Group | $1,231.60 -0.2% | 3/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $1,050.00 -> $1,175.00 | Low | View details for JPMorgan Chase & Co. rating of TransDigm Group (NYSE:TDG) on 3/27/2024 |
ORIC ORIC Pharmaceuticals | $13.75 +2.2% | 3/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $19.00 -> $18.00 | Low | View details for JPMorgan Chase & Co. rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/27/2024 |
PRGS Progress Software | $53.31 +1.3% | 3/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $65.00 -> $63.00 | Low | View details for JPMorgan Chase & Co. rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
RAPT RAPT Therapeutics | $8.98 +0.6% | 3/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $13.00 | Low | View details for JPMorgan Chase & Co. rating of RAPT Therapeutics (NASDAQ:RAPT) on 3/27/2024 |
KBH KB Home | $70.85 +1.9% | 3/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.50 -> $70.50 | Low | View details for JPMorgan Chase & Co. rating of KB Home (NYSE:KBH) on 3/27/2024 |
SAGE Sage Therapeutics | $18.74 -1.6% | 3/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $24.00 -> $29.00 | Low | View details for JPMorgan Chase & Co. rating of Sage Therapeutics (NASDAQ:SAGE) on 3/26/2024 |
STOK Stoke Therapeutics | $13.50 -4.7% | 3/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $6.00 -> $13.00 | Low | View details for JPMorgan Chase & Co. rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
LAZR Luminar Technologies | $1.97 +10.7% | 3/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $8.00 | Low | View details for JPMorgan Chase & Co. rating of Luminar Technologies (NASDAQ:LAZR) on 3/26/2024 |
INVZ Innoviz Technologies | $1.35 +1.5% | 3/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.00 -> $7.00 | Low | View details for JPMorgan Chase & Co. rating of Innoviz Technologies (NASDAQ:INVZ) on 3/26/2024 |
ALTR Altair Engineering | $86.15 -0.1% | 3/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $86.00 -> $95.00 | Low | View details for JPMorgan Chase & Co. rating of Altair Engineering (NASDAQ:ALTR) on 3/26/2024 |
PKI Parkland | C$43.14 +0.3% | 3/25/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | C$51.00 -> C$56.00 | N/A | View details for JPMorgan Chase & Co. rating of Parkland (TSE:PKI) on 3/25/2024 |
LYB LyondellBasell Industries | $102.28 -0.7% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $100.00 -> $105.00 | Low | View details for JPMorgan Chase & Co. rating of LyondellBasell Industries (NYSE:LYB) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $120.42 -0.1% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $170.00 -> $190.00 | Low | View details for JPMorgan Chase & Co. rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
HTHT H World Group | $38.70 +0.1% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $40.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of H World Group (NASDAQ:HTHT) on 3/22/2024 |
LULU Lululemon Athletica | $390.65 +0.3% | 3/22/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $531.00 -> $509.00 | Low | View details for JPMorgan Chase & Co. rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
ZIM ZIM Integrated Shipping Services | $10.12 +1.0% | 3/22/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $9.30 -> $9.25 | Low | View details for JPMorgan Chase & Co. rating of ZIM Integrated Shipping Services (NYSE:ZIM) on 3/22/2024 |
BA Boeing | $192.83 +0.5% | 3/25/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $270.00 -> $230.00 | Low | View details for JPMorgan Chase & Co. rating of Boeing (NYSE:BA) on 3/25/2024 |
ACAD ACADIA Pharmaceuticals | $18.49 +1.6% | 3/25/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $29.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 3/25/2024 |
CMI Cummins | $294.61 0.0% | 3/25/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $245.00 -> $275.00 | Low | View details for JPMorgan Chase & Co. rating of Cummins (NYSE:CMI) on 3/25/2024 |
MNDY monday.com | $225.87 -0.4% | 3/25/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $230.00 -> $270.00 | Low | View details for JPMorgan Chase & Co. rating of monday.com (NASDAQ:MNDY) on 3/25/2024 |
ATMU Atmus Filtration Technologies | $32.25 +1.0% | 3/25/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $27.00 -> $36.00 | Low | View details for JPMorgan Chase & Co. rating of Atmus Filtration Technologies (NYSE:ATMU) on 3/25/2024 |
CART Maplebear | $37.29 +0.5% | 3/25/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $35.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of Maplebear (NASDAQ:CART) on 3/25/2024 |
SMCI Super Micro Computer | $1,010.03 -1.3% | 3/25/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $1,150.00 | Low | View details for JPMorgan Chase & Co. rating of Super Micro Computer (NASDAQ:SMCI) on 3/25/2024 |
LAW CS Disco | $8.13 +4.5% | 3/25/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $9.00 | Low | View details for JPMorgan Chase & Co. rating of CS Disco (NYSE:LAW) on 3/25/2024 |
BNTX BioNTech | $92.25 -0.8% | 3/22/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $99.00 -> $90.00 | Low | View details for JPMorgan Chase & Co. rating of BioNTech (NASDAQ:BNTX) on 3/22/2024 |
LZ LegalZoom.com | $13.34 +0.5% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $14.00 -> $16.00 | Low | View details for JPMorgan Chase & Co. rating of LegalZoom.com (NASDAQ:LZ) on 3/22/2024 |
DD DuPont de Nemours | $76.66 +0.2% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $76.00 -> $85.00 | Low | View details for JPMorgan Chase & Co. rating of DuPont de Nemours (NYSE:DD) on 3/22/2024 |
PDD PDD | $116.25 -0.4% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $195.00 -> $190.00 | Low | View details for JPMorgan Chase & Co. rating of PDD (NASDAQ:PDD) on 3/21/2024 |
PGEN Precigen | $1.45
| 3/22/2024 | Downgraded by | JPMorgan Chase & Co. | - | Neutral -> Underweight | | Low | View details for JPMorgan Chase & Co. rating of Precigen (NASDAQ:PGEN) on 3/22/2024 |
VMC Vulcan Materials | $272.92 +0.0% | 3/22/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $245.00 -> $270.00 | Low | View details for JPMorgan Chase & Co. rating of Vulcan Materials (NYSE:VMC) on 3/22/2024 |
MLM Martin Marietta Materials | $613.94 +0.3% | 3/22/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $530.00 -> $600.00 | Low | View details for JPMorgan Chase & Co. rating of Martin Marietta Materials (NYSE:MLM) on 3/22/2024 |
EXP Eagle Materials | $271.75 +1.0% | 3/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $200.00 -> $265.00 | Low | View details for JPMorgan Chase & Co. rating of Eagle Materials (NYSE:EXP) on 3/22/2024 |
BBY Best Buy | $82.03 +0.2% | 3/22/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $89.00 -> $101.00 | Low | View details for JPMorgan Chase & Co. rating of Best Buy (NYSE:BBY) on 3/22/2024 |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
IMCR Immunocore | $65.00 +2.2% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for JPMorgan Chase & Co. rating of Immunocore (NASDAQ:IMCR) on 3/20/2024 |
DCPH Deciphera Pharmaceuticals | $15.73 +3.6% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $14.00 -> $16.00 | Low | View details for JPMorgan Chase & Co. rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 3/20/2024 |
ZTO ZTO Express (Cayman) | $20.94 -1.6% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $37.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of ZTO Express (Cayman) (NYSE:ZTO) on 3/21/2024 |
CHWY Chewy | $15.90 +1.6% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $25.00 -> $22.00 | Low | View details for JPMorgan Chase & Co. rating of Chewy (NYSE:CHWY) on 3/21/2024 |
NWG NatWest Group | GBX 265.50 +1.0% | 3/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | GBX 270 | N/A | View details for JPMorgan Chase & Co. rating of NatWest Group (LON:NWG) on 3/21/2024 |
ROK Rockwell Automation | $291.33 +0.0% | 3/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $254.00 | Low | View details for JPMorgan Chase & Co. rating of Rockwell Automation (NYSE:ROK) on 3/21/2024 |
GIS General Mills | $69.95 +0.4% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.00 -> $72.00 | Low | View details for JPMorgan Chase & Co. rating of General Mills (NYSE:GIS) on 3/21/2024 |
GS The Goldman Sachs Group | $417.69 +0.6% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $421.00 -> $424.00 | Low | View details for JPMorgan Chase & Co. rating of The Goldman Sachs Group (NYSE:GS) on 3/21/2024 |
HII Huntington Ingalls Industries | $291.48 +0.6% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $288.00 -> $295.00 | Low | View details for JPMorgan Chase & Co. rating of Huntington Ingalls Industries (NYSE:HII) on 3/21/2024 |
KGS Kodiak Gas Services | $27.34 +3.4% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $27.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of Kodiak Gas Services (NYSE:KGS) on 3/21/2024 |
NWE NorthWestern Energy Group | $50.93 +1.3% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $53.00 -> $54.00 | Low | View details for JPMorgan Chase & Co. rating of NorthWestern Energy Group (NYSE:NWE) on 3/21/2024 |
TX Ternium | $41.62 -0.6% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $48.00 -> $51.50 | Low | View details for JPMorgan Chase & Co. rating of Ternium (NYSE:TX) on 3/21/2024 |
EVE EVe Mobility Acquisition | $10.94
| 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.50 -> $12.50 | Low | View details for JPMorgan Chase & Co. rating of EVe Mobility Acquisition (NYSE:EVE) on 3/21/2024 |
SCCO Southern Copper | $106.46 +2.1% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $63.50 -> $61.00 | Low | View details for JPMorgan Chase & Co. rating of Southern Copper (NYSE:SCCO) on 3/21/2024 |
OLLI Ollie's Bargain Outlet | $79.57 +1.0% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $88.00 -> $85.00 | Low | View details for JPMorgan Chase & Co. rating of Ollie’s Bargain Outlet (NASDAQ:OLLI) on 3/21/2024 |
AVGO Broadcom | $1,325.41 +0.5% | 3/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $1,700.00 | Low | View details for JPMorgan Chase & Co. rating of Broadcom (NASDAQ:AVGO) on 3/21/2024 |
FIVE Five Below | $181.38 -1.3% | 3/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $222.00 -> $215.00 | Low | View details for JPMorgan Chase & Co. rating of Five Below (NASDAQ:FIVE) on 3/21/2024 |
MU Micron Technology | $117.89 -1.1% | 3/21/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $105.00 -> $130.00 | Low | View details for JPMorgan Chase & Co. rating of Micron Technology (NASDAQ:MU) on 3/21/2024 |
SNDX Syndax Pharmaceuticals | $23.80 +3.2% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $31.00 -> $34.00 | Low | View details for JPMorgan Chase & Co. rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 3/20/2024 |
NVCR NovoCure | $15.63 +6.8% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of NovoCure (NASDAQ:NVCR) on 3/19/2024 |
BGNE BeiGene | $156.39 +0.8% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $184.00 -> $186.00 | Low | View details for JPMorgan Chase & Co. rating of BeiGene (NASDAQ:BGNE) on 3/19/2024 |
CNM Core & Main | $57.23 +0.8% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $38.00 -> $54.00 | Low | View details for JPMorgan Chase & Co. rating of Core & Main (NYSE:CNM) on 3/19/2024 |
SUN Sunoco | $60.30 +0.2% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $53.00 -> $62.00 | Low | View details for JPMorgan Chase & Co. rating of Sunoco (NYSE:SUN) on 3/19/2024 |
SAIC Science Applications International | $130.39 +0.2% | 3/19/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $142.00 -> $140.00 | Low | View details for JPMorgan Chase & Co. rating of Science Applications International (NYSE:SAIC) on 3/19/2024 |
RIOT Riot Platforms | $12.24
| 3/20/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $15.00 | N/A | View details for JPMorgan Chase & Co. rating of Riot Platforms (NASDAQ:RIOT) on 3/20/2024 |
EQT EQT | $37.08 +2.8% | 3/20/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $39.00 -> $37.00 | Low | View details for JPMorgan Chase & Co. rating of EQT (NYSE:EQT) on 3/20/2024 |
BBIO BridgeBio Pharma | $30.92 +0.2% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $35.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/20/2024 |
ASO Academy Sports and Outdoors | $67.54 -0.5% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $55.00 -> $87.00 | Low | View details for JPMorgan Chase & Co. rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/20/2024 |
NBIX Neurocrine Biosciences | $137.92 +0.1% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $148.00 -> $158.00 | Low | View details for JPMorgan Chase & Co. rating of Neurocrine Biosciences (NASDAQ:NBIX) on 3/20/2024 |
AR Antero Resources | $29.00 +1.0% | 3/20/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $27.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Antero Resources (NYSE:AR) on 3/20/2024 |
PSON Pearson | GBX 1,042 +0.7% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 1,200 -> GBX 1,220 | N/A | View details for JPMorgan Chase & Co. rating of Pearson (LON:PSON) on 3/20/2024 |
JUST Just Group | GBX 105.20 -0.9% | 3/20/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 135 -> GBX 160 | N/A | View details for JPMorgan Chase & Co. rating of Just Group (LON:JUST) on 3/20/2024 |
DAVA Endava | $38.04 +0.6% | 3/19/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $49.00 | Low | View details for JPMorgan Chase & Co. rating of Endava (NYSE:DAVA) on 3/19/2024 |
MRSN Mersana Therapeutics | $4.48 -0.2% | 3/19/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $5.00 | Low | View details for JPMorgan Chase & Co. rating of Mersana Therapeutics (NASDAQ:MRSN) on 3/19/2024 |
EAT Brinker International | $49.67 +1.3% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $44.00 -> $48.00 | Low | View details for JPMorgan Chase & Co. rating of Brinker International (NYSE:EAT) on 3/19/2024 |
DRI Darden Restaurants | $167.15 +0.1% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $170.00 -> $180.00 | Low | View details for JPMorgan Chase & Co. rating of Darden Restaurants (NYSE:DRI) on 3/19/2024 |
BROS Dutch Bros | $33.00 -0.5% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $34.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of Dutch Bros (NYSE:BROS) on 3/19/2024 |
DNUT Krispy Kreme | $15.24 -0.8% | 3/19/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $14.00 -> $13.00 | Low | View details for JPMorgan Chase & Co. rating of Krispy Kreme (NASDAQ:DNUT) on 3/19/2024 |
SBUX Starbucks | $91.39 -0.1% | 3/19/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $107.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Starbucks (NASDAQ:SBUX) on 3/19/2024 |
SG Sweetgreen | $25.25 -0.9% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of Sweetgreen (NYSE:SG) on 3/19/2024 |
SYY Sysco | $81.18 -0.9% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $84.00 -> $87.00 | Low | View details for JPMorgan Chase & Co. rating of Sysco (NYSE:SYY) on 3/19/2024 |
TXRH Texas Roadhouse | $154.47 +0.1% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $142.00 -> $145.00 | Low | View details for JPMorgan Chase & Co. rating of Texas Roadhouse (NASDAQ:TXRH) on 3/19/2024 |
USFD US Foods | $53.97 -1.0% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $50.00 -> $52.00 | Low | View details for JPMorgan Chase & Co. rating of US Foods (NYSE:USFD) on 3/19/2024 |
YUM Yum! Brands | $138.65 +1.0% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $133.00 -> $134.00 | Low | View details for JPMorgan Chase & Co. rating of Yum! Brands (NYSE:YUM) on 3/19/2024 |
CAVA CAVA Group | $70.05 +1.3% | 3/19/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $50.00 -> $64.00 | Low | View details for JPMorgan Chase & Co. rating of CAVA Group (NYSE:CAVA) on 3/19/2024 |
KSS Kohl's | $29.16 +2.5% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $20.00 -> $21.00 | Low | View details for JPMorgan Chase & Co. rating of Kohl’s (NYSE:KSS) on 3/13/2024 |
CMS CMS Energy | $60.34 +0.7% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $65.00 -> $66.00 | Low | View details for JPMorgan Chase & Co. rating of CMS Energy (NYSE:CMS) on 3/13/2024 |
DTE DTE Energy | $112.07 +0.7% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $118.00 -> $120.00 | Low | View details for JPMorgan Chase & Co. rating of DTE Energy (NYSE:DTE) on 3/13/2024 |
ITRI Itron | $92.52 +1.1% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $77.00 -> $92.00 | Low | View details for JPMorgan Chase & Co. rating of Itron (NASDAQ:ITRI) on 3/13/2024 |
OKE ONEOK | $80.17 +0.7% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $81.00 -> $85.00 | Low | View details for JPMorgan Chase & Co. rating of ONEOK (NYSE:OKE) on 3/13/2024 |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
USPH U.S. Physical Therapy | $112.86 +1.7% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $99.00 -> $117.00 | Low | View details for JPMorgan Chase & Co. rating of U.S. Physical Therapy (NYSE:USPH) on 3/13/2024 |
UHS Universal Health Services | $182.46 +0.3% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $144.00 -> $182.00 | Low | View details for JPMorgan Chase & Co. rating of Universal Health Services (NYSE:UHS) on 3/13/2024 |
VEEV Veeva Systems | $231.89 -0.6% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $183.00 -> $222.00 | Low | View details for JPMorgan Chase & Co. rating of Veeva Systems (NYSE:VEEV) on 3/13/2024 |
INNV InnovAge | $4.44 +2.3% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $7.00 -> $6.00 | Low | View details for JPMorgan Chase & Co. rating of InnovAge (NASDAQ:INNV) on 3/13/2024 |
XEL Xcel Energy | $53.75 +0.7% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.00 -> $59.00 | Low | View details for JPMorgan Chase & Co. rating of Xcel Energy (NASDAQ:XEL) on 3/13/2024 |
FLUT Flutter Entertainment | $197.49 -2.4% | 3/13/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | | Low | View details for JPMorgan Chase & Co. rating of Flutter Entertainment (NYSE:FLUT) on 3/13/2024 |
ADBE Adobe | $504.60 +0.0% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $600.00 -> $570.00 | Low | View details for JPMorgan Chase & Co. rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
COIN Coinbase Global | $265.12 +3.3% | 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $95.00 -> $150.00 | N/A | View details for JPMorgan Chase & Co. rating of Coinbase Global (NASDAQ:COIN) on 3/15/2024 |
LLY Eli Lilly and Company | $777.96 0.0% | 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $775.00 -> $850.00 | Low | View details for JPMorgan Chase & Co. rating of Eli Lilly and Company (NYSE:LLY) on 3/15/2024 |
DOCS Doximity | $26.91 -0.3% | 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $22.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of Doximity (NASDAQ:DOCS) on 3/15/2024 |
EVH Evolent Health | $32.79 +0.2% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $53.00 -> $52.00 | Low | View details for JPMorgan Chase & Co. rating of Evolent Health (NYSE:EVH) on 3/15/2024 |
DRS Leonardo DRS | $22.09 +1.2% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $25.00 -> $24.00 | Low | View details for JPMorgan Chase & Co. rating of Leonardo DRS (NASDAQ:DRS) on 3/15/2024 |
SMAR Smartsheet | $38.50 +0.3% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $54.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
WCC WESCO International | $171.24 +0.2% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $180.00 -> $175.00 | Low | View details for JPMorgan Chase & Co. rating of WESCO International (NYSE:WCC) on 3/15/2024 |
FOLD Amicus Therapeutics | $11.78 -0.7% | 3/18/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $21.00 -> $19.00 | Low | View details for JPMorgan Chase & Co. rating of Amicus Therapeutics (NASDAQ:FOLD) on 3/18/2024 |
RARE Ultragenyx Pharmaceutical | $46.69 -0.3% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $88.00 -> $92.00 | Low | View details for JPMorgan Chase & Co. rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 3/18/2024 |
LEN Lennar | $171.98 +2.1% | 3/18/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $161.00 -> $157.00 | Low | View details for JPMorgan Chase & Co. rating of Lennar (NYSE:LEN) on 3/18/2024 |
NMRA Neumora Therapeutics | $13.75 +9.0% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $22.00 | Low | View details for JPMorgan Chase & Co. rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/18/2024 |
LAC Lithium Americas | $6.72 -0.3% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | $5.50 -> $7.00 | Low | View details for JPMorgan Chase & Co. rating of Lithium Americas (NYSE:LAC) on 3/18/2024 |
M Macy's | $19.98 +0.7% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $23.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of Macy’s (NYSE:M) on 3/18/2024 |
ESAB ESAB | $110.57 +0.4% | 3/18/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $111.00 -> $125.00 | Low | View details for JPMorgan Chase & Co. rating of ESAB (NYSE:ESAB) on 3/18/2024 |
TEX Terex | $64.39 -0.2% | 3/18/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $63.00 | Low | View details for JPMorgan Chase & Co. rating of Terex (NYSE:TEX) on 3/18/2024 |
EVCM EverCommerce | $9.42 +1.2% | 3/15/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $11.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of EverCommerce (NASDAQ:EVCM) on 3/15/2024 |
DLTR Dollar Tree | $133.15 +0.5% | 3/14/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $165.00 -> $144.00 | Low | View details for JPMorgan Chase & Co. rating of Dollar Tree (NASDAQ:DLTR) on 3/14/2024 |
PATH UiPath | $22.67 -0.5% | 3/14/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $22.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of UiPath (NYSE:PATH) on 3/14/2024 |
ATD Alimentation Couche-Tard | C$77.31 +0.1% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | | C$80.00 -> C$79.00 | N/A | View details for JPMorgan Chase & Co. rating of Alimentation Couche-Tard (TSE:ATD) on 3/13/2024 |
NRDY Nerdy | $2.91 -0.7% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $5.00 | Low | View details for JPMorgan Chase & Co. rating of Nerdy (NYSE:NRDY) on 3/11/2024 |
COO Cooper Companies | $101.46 -0.4% | 3/13/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $100.00 -> $120.00 | Low | View details for JPMorgan Chase & Co. rating of Cooper Companies (NASDAQ:COO) on 3/13/2024 |
MEG MEG Energy | C$31.10 +0.8% | 3/12/2024 | Target Raised by | JPMorgan Chase & Co. | - | | C$33.00 -> C$34.00 | N/A | View details for JPMorgan Chase & Co. rating of MEG Energy (TSE:MEG) on 3/12/2024 |
BARC Barclays | GBX 183.20 +0.9% | 3/12/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | | N/A | View details for JPMorgan Chase & Co. rating of Barclays (LON:BARC) on 3/12/2024 |
DG Dollar General | $156.24 +1.3% | 3/12/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $120.00 -> $158.00 | Low | View details for JPMorgan Chase & Co. rating of Dollar General (NYSE:DG) on 3/12/2024 |
SAIA Saia | $585.00 +0.8% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $676.00 | Low | View details for JPMorgan Chase & Co. rating of Saia (NASDAQ:SAIA) on 3/11/2024 |
ODFL Old Dominion Freight Line | $219.31 -48.8% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $232.50 | Low | View details for JPMorgan Chase & Co. rating of Old Dominion Freight Line (NASDAQ:ODFL) on 3/11/2024 |
KSPI Joint Stock Company Kaspi.kz | $128.64 +2.2% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $159.00 | Low | View details for JPMorgan Chase & Co. rating of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) on 3/11/2024 |
DUOL Duolingo | $220.58 -0.9% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $270.00 | Low | View details for JPMorgan Chase & Co. rating of Duolingo (NASDAQ:DUOL) on 3/11/2024 |
ARCB ArcBest | $142.50 +3.9% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $168.00 | Low | View details for JPMorgan Chase & Co. rating of ArcBest (NASDAQ:ARCB) on 3/11/2024 |
KC Kingsoft Cloud | $3.04 +3.8% | 3/11/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | | Low | View details for JPMorgan Chase & Co. rating of Kingsoft Cloud (NASDAQ:KC) on 3/11/2024 |
BILI Bilibili | $11.20 +1.5% | 3/11/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $10.00 -> $11.00 | Low | View details for JPMorgan Chase & Co. rating of Bilibili (NASDAQ:BILI) on 3/11/2024 |
VET Vermilion Energy | C$16.84 +1.4% | 3/8/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | C$23.00 -> C$21.00 | N/A | View details for JPMorgan Chase & Co. rating of Vermilion Energy (TSE:VET) on 3/8/2024 |
TEVA Teva Pharmaceutical Industries | $14.10 -2.3% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $14.00 | Low | View details for JPMorgan Chase & Co. rating of Teva Pharmaceutical Industries (NYSE:TEVA) on 3/8/2024 |
RWAY Runway Growth Finance | $12.12
| 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $13.50 -> $12.50 | Low | View details for JPMorgan Chase & Co. rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
KGS Kodiak Gas Services | $27.34 +3.4% | 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $27.00 | Low | View details for JPMorgan Chase & Co. rating of Kodiak Gas Services (NYSE:KGS) on 3/8/2024 |
HESM Hess Midstream | $36.13 +0.8% | 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $37.00 | Low | View details for JPMorgan Chase & Co. rating of Hess Midstream (NYSE:HESM) on 3/8/2024 |
KNTK Kinetik | $39.83 +1.3% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $38.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of Kinetik (NASDAQ:KNTK) on 3/8/2024 |
GE General Electric | $175.47 -2.6% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $166.00 -> $180.00 | Low | View details for JPMorgan Chase & Co. rating of General Electric (NYSE:GE) on 3/8/2024 |
SSE SSE | GBX 1,650 -0.5% | 3/7/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Top Pick | GBX 2,125 -> GBX 2,050 | N/A | View details for JPMorgan Chase & Co. rating of SSE (LON:SSE) on 3/7/2024 |
LRE Lancashire | GBX 619 -0.8% | 3/7/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral | GBX 750 | N/A | View details for JPMorgan Chase & Co. rating of Lancashire (LON:LRE) on 3/7/2024 |
CTEC ConvaTec Group | GBX 286.40 -1.0% | 3/7/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 300 -> GBX 323 | N/A | View details for JPMorgan Chase & Co. rating of ConvaTec Group (LON:CTEC) on 3/7/2024 |
PCRX Pacira BioSciences | $29.22 +0.6% | 3/7/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $80.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of Pacira BioSciences (NASDAQ:PCRX) on 3/7/2024 |
VSCO Victoria's Secret & Co. | $19.39 +2.4% | 3/7/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $22.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of Victoria’s Secret & Co. (NYSE:VSCO) on 3/7/2024 |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
FM First Quantum Minerals | C$14.56 +2.3% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | C$11.00 -> C$12.00 | N/A | View details for JPMorgan Chase & Co. rating of First Quantum Minerals (TSE:FM) on 3/6/2024 |
HSIC Henry Schein | $75.52 +0.5% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $82.00 -> $88.00 | Low | View details for JPMorgan Chase & Co. rating of Henry Schein (NASDAQ:HSIC) on 3/6/2024 |
NUVL Nuvalent | $75.09 -2.0% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $68.00 -> $98.00 | Low | View details for JPMorgan Chase & Co. rating of Nuvalent (NASDAQ:NUVL) on 3/6/2024 |
PAY Paymentus | $22.75 +1.2% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $17.00 -> $19.00 | N/A | View details for JPMorgan Chase & Co. rating of Paymentus (NYSE:PAY) on 3/6/2024 |
AKYA Akoya Biosciences | $4.69 -0.8% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $12.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Akoya Biosciences (NASDAQ:AKYA) on 3/6/2024 |
CCOI Cogent Communications | $65.33 +0.8% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $74.00 -> $73.00 | Low | View details for JPMorgan Chase & Co. rating of Cogent Communications (NASDAQ:CCOI) on 3/6/2024 |
HR Healthcare Realty Trust | $14.15 +1.5% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $19.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of Healthcare Realty Trust (NYSE:HR) on 3/6/2024 |
PDCO Patterson Companies | $27.65 -0.5% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $31.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Patterson Companies (NASDAQ:PDCO) on 3/6/2024 |
PRVA Privia Health Group | $19.59 +0.2% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $38.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Privia Health Group (NASDAQ:PRVA) on 3/6/2024 |
APLS Apellis Pharmaceuticals | $58.78 +0.5% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $78.00 -> $79.00 | Low | View details for JPMorgan Chase & Co. rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 3/6/2024 |
APG APi Group | $39.27 -0.7% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $31.00 -> $35.00 | Low | View details for JPMorgan Chase & Co. rating of APi Group (NYSE:APG) on 3/6/2024 |
CRWD CrowdStrike | $320.59 -0.5% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $350.00 -> $371.00 | N/A | View details for JPMorgan Chase & Co. rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
SG Sweetgreen | $25.25 -0.9% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.00 -> $20.00 | Low | View details for JPMorgan Chase & Co. rating of Sweetgreen (NYSE:SG) on 3/6/2024 |
SWTX SpringWorks Therapeutics | $49.22 -1.8% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $73.00 -> $74.00 | Low | View details for JPMorgan Chase & Co. rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 3/6/2024 |
TRGP Targa Resources | $111.99 +0.8% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $122.00 -> $125.00 | Low | View details for JPMorgan Chase & Co. rating of Targa Resources (NYSE:TRGP) on 3/6/2024 |
ROST Ross Stores | $146.76 -0.3% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $150.00 -> $163.00 | Low | View details for JPMorgan Chase & Co. rating of Ross Stores (NASDAQ:ROST) on 3/6/2024 |
JWN Nordstrom | $20.27 +1.8% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $14.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of Nordstrom (NYSE:JWN) on 3/6/2024 |
NIO NIO | $4.51 -3.6% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $5.00 -> $4.80 | Low | View details for JPMorgan Chase & Co. rating of NIO (NYSE:NIO) on 3/6/2024 |
BOX BOX | $28.32 -0.3% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $31.00 -> $32.00 | Low | View details for JPMorgan Chase & Co. rating of BOX (NYSE:BOX) on 3/6/2024 |
TBBB BBB Foods | $23.79 -2.9% | 3/6/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $30.00 | N/A | View details for JPMorgan Chase & Co. rating of BBB Foods (NYSE:TBBB) on 3/6/2024 |
ICAGY International Consolidated Airlines Group | $4.39 +2.6% | 3/6/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Overweight | | N/A | View details for JPMorgan Chase & Co. rating of International Consolidated Airlines Group (OTCMKTS:ICAGY) on 3/6/2024 |
PSON Pearson | GBX 1,042 +0.7% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 1,160 -> GBX 1,200 | N/A | View details for JPMorgan Chase & Co. rating of Pearson (LON:PSON) on 3/5/2024 |
SDR Schroders | GBX 376.60 +1.1% | 3/5/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | GBX 490 -> GBX 489 | N/A | View details for JPMorgan Chase & Co. rating of Schroders (LON:SDR) on 3/5/2024 |
CKN Clarkson | GBX 4,010 +0.1% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 4,080 -> GBX 4,320 | N/A | View details for JPMorgan Chase & Co. rating of Clarkson (LON:CKN) on 3/5/2024 |
HWDN Howden Joinery Group | GBX 906.80 +1.5% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | GBX 670 -> GBX 680 | N/A | View details for JPMorgan Chase & Co. rating of Howden Joinery Group (LON:HWDN) on 3/5/2024 |
TRST Trustpilot Group | GBX 198.80 +3.2% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 190 -> GBX 250 | N/A | View details for JPMorgan Chase & Co. rating of Trustpilot Group (LON:TRST) on 3/5/2024 |
PCAR PACCAR | $123.89 -0.5% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $116.00 -> $135.00 | Low | View details for JPMorgan Chase & Co. rating of PACCAR (NASDAQ:PCAR) on 3/5/2024 |
DDL Dingdong (Cayman) | $1.22 +1.7% | 3/5/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $1.40 -> $1.15 | Low | View details for JPMorgan Chase & Co. rating of Dingdong (Cayman) (NYSE:DDL) on 3/5/2024 |
CIEN Ciena | $49.45 -2.1% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $56.00 -> $67.00 | Low | View details for JPMorgan Chase & Co. rating of Ciena (NYSE:CIEN) on 3/5/2024 |
MGX Metagenomi | $10.55 -4.9% | 3/5/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $16.00 | Low | View details for JPMorgan Chase & Co. rating of Metagenomi (NASDAQ:MGX) on 3/5/2024 |
AMPH Amphastar Pharmaceuticals | $43.91 +0.9% | 3/5/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $60.00 | Low | View details for JPMorgan Chase & Co. rating of Amphastar Pharmaceuticals (NASDAQ:AMPH) on 3/5/2024 |
SE SEA | $53.72 +0.3% | 3/5/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $43.00 -> $70.00 | Low | View details for JPMorgan Chase & Co. rating of SEA (NYSE:SE) on 3/5/2024 |
CNQ Canadian Natural Resources | C$103.33 +0.9% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | | C$102.00 -> C$106.00 | N/A | View details for JPMorgan Chase & Co. rating of Canadian Natural Resources (TSE:CNQ) on 3/4/2024 |
SHAK Shake Shack | $104.03 -0.2% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $65.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Shake Shack (NYSE:SHAK) on 3/4/2024 |
GE General Electric | $175.47 -2.6% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $134.00 -> $166.00 | Low | View details for JPMorgan Chase & Co. rating of General Electric (NYSE:GE) on 3/4/2024 |
COMM CommScope | $1.31 +3.1% | 3/4/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | | Low | View details for JPMorgan Chase & Co. rating of CommScope (NASDAQ:COMM) on 3/4/2024 |
KYTX Kyverna Therapeutics | $24.84 +3.0% | 3/4/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $39.00 | Low | View details for JPMorgan Chase & Co. rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024 |
MCB Metropolitan Bank | $38.50 +1.2% | 3/4/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $62.00 -> $55.00 | Low | View details for JPMorgan Chase & Co. rating of Metropolitan Bank (NYSE:MCB) on 3/4/2024 |
STJ St. James's Place | GBX 464.50 +2.7% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral | GBX 793 -> GBX 637 | N/A | View details for JPMorgan Chase & Co. rating of St. James’s Place (LON:STJ) on 3/1/2024 |
PHP Primary Health Properties | GBX 93.75 -1.3% | 3/1/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | GBX 105 | N/A | View details for JPMorgan Chase & Co. rating of Primary Health Properties (LON:PHP) on 3/1/2024 |
STER Sterling Check | $16.08 -0.9% | 3/1/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $17.00 | Low | View details for JPMorgan Chase & Co. rating of Sterling Check (NASDAQ:STER) on 3/1/2024 |
FIHL Fidelis Insurance | $19.48 +2.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $16.00 | Low | View details for JPMorgan Chase & Co. rating of Fidelis Insurance (NYSE:FIHL) on 3/1/2024 |
HRL Hormel Foods | $34.89 +0.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $27.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of Hormel Foods (NYSE:HRL) on 3/1/2024 |
NTAP NetApp | $104.97 -0.2% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $87.00 -> $95.00 | Low | View details for JPMorgan Chase & Co. rating of NetApp (NASDAQ:NTAP) on 3/1/2024 |
SE SEA | $53.72 +0.3% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $40.00 -> $43.00 | Low | View details for JPMorgan Chase & Co. rating of SEA (NYSE:SE) on 3/1/2024 |
TGT Target | $177.12 +1.4% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $125.00 -> $157.00 | Low | View details for JPMorgan Chase & Co. rating of Target (NYSE:TGT) on 3/1/2024 |
COO Cooper Companies | $101.46 -0.4% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $94.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Cooper Companies (NASDAQ:COO) on 3/1/2024 |
TREX Trex | $99.84 +0.6% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $79.00 -> $93.00 | Low | View details for JPMorgan Chase & Co. rating of Trex (NYSE:TREX) on 3/1/2024 |
VTEX VTEX | $8.15 -0.9% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $6.50 -> $9.00 | Low | View details for JPMorgan Chase & Co. rating of VTEX (NYSE:VTEX) on 3/1/2024 |
FRO Frontline | $23.39 +0.5% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $23.00 -> $22.30 | Low | View details for JPMorgan Chase & Co. rating of Frontline (NYSE:FRO) on 3/1/2024 |
This consistently signaled gains of 453%... 610%... and even 1036%... (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
TGNA TEGNA | $14.94 +0.6% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $17.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of TEGNA (NYSE:TGNA) on 3/1/2024 |
WHF WhiteHorse Finance | $12.40 -1.2% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $12.00 -> $11.50 | Low | View details for JPMorgan Chase & Co. rating of WhiteHorse Finance (NASDAQ:WHF) on 3/1/2024 |
BBY Best Buy | $82.03 +0.2% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $78.00 -> $89.00 | Low | View details for JPMorgan Chase & Co. rating of Best Buy (NYSE:BBY) on 3/1/2024 |
BJ BJ's Wholesale Club | $75.65 -1.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $58.00 -> $62.00 | Low | View details for JPMorgan Chase & Co. rating of BJ’s Wholesale Club (NYSE:BJ) on 3/1/2024 |
ESAB ESAB | $110.57 +0.4% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $84.00 -> $111.00 | Low | View details for JPMorgan Chase & Co. rating of ESAB (NYSE:ESAB) on 3/1/2024 |
CPB Campbell Soup | $44.45 +0.9% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $47.00 -> $48.00 | Low | View details for JPMorgan Chase & Co. rating of Campbell Soup (NYSE:CPB) on 3/1/2024 |
DAVA Endava | $38.04 +0.6% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $79.00 -> $49.00 | Low | View details for JPMorgan Chase & Co. rating of Endava (NYSE:DAVA) on 3/1/2024 |
ACAD ACADIA Pharmaceuticals | $18.49 +1.6% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $32.00 -> $29.00 | Low | View details for JPMorgan Chase & Co. rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 3/1/2024 |
MEG Montrose Environmental Group | $39.17 +2.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $41.00 -> $47.00 | N/A | View details for JPMorgan Chase & Co. rating of Montrose Environmental Group (NYSE:MEG) on 3/1/2024 |
H Hyatt Hotels | $159.60 -0.8% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $162.00 -> $172.00 | N/A | View details for JPMorgan Chase & Co. rating of Hyatt Hotels (NYSE:H) on 3/1/2024 |
GDRX GoodRx | $7.10 +1.3% | 3/1/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $7.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of GoodRx (NASDAQ:GDRX) on 3/1/2024 |
ABEV Ambev | $2.48
| 3/1/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | | Low | View details for JPMorgan Chase & Co. rating of Ambev (NYSE:ABEV) on 3/1/2024 |
ANNX Annexon | $7.17 -8.2% | 3/1/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $11.00 | Low | View details for JPMorgan Chase & Co. rating of Annexon (NASDAQ:ANNX) on 3/1/2024 |
NXT Nextracker | $56.27 -3.0% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $73.00 -> $67.00 | Low | View details for JPMorgan Chase & Co. rating of Nextracker (NASDAQ:NXT) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.18 -4.9% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $32.00 -> $26.00 | Low | View details for JPMorgan Chase & Co. rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SLRC SLR Investment | $15.35 +0.3% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.50 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of SLR Investment (NASDAQ:SLRC) on 2/29/2024 |
SNOW Snowflake | $161.43 +0.9% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $200.00 -> $170.00 | Low | View details for JPMorgan Chase & Co. rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
AAP Advance Auto Parts | $85.09 -0.3% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $55.00 -> $68.00 | Low | View details for JPMorgan Chase & Co. rating of Advance Auto Parts (NYSE:AAP) on 2/29/2024 |
ALKT Alkami Technology | $24.57 +2.4% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $27.00 -> $31.00 | Low | View details for JPMorgan Chase & Co. rating of Alkami Technology (NASDAQ:ALKT) on 2/29/2024 |
AVDX AvidXchange | $13.15 +0.2% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $14.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of AvidXchange (NASDAQ:AVDX) on 2/29/2024 |
CAVA CAVA Group | $70.05 +1.3% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of CAVA Group (NYSE:CAVA) on 2/29/2024 |
BAP Credicorp | $169.43 +0.8% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $190.00 -> $194.00 | Low | View details for JPMorgan Chase & Co. rating of Credicorp (NYSE:BAP) on 2/29/2024 |
CRWD CrowdStrike | $320.59 -0.5% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $300.00 -> $350.00 | Low | View details for JPMorgan Chase & Co. rating of CrowdStrike (NASDAQ:CRWD) on 2/29/2024 |
ESTA Establishment Labs | $50.90 +0.3% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $46.00 -> $53.00 | Low | View details for JPMorgan Chase & Co. rating of Establishment Labs (NASDAQ:ESTA) on 2/29/2024 |
PSTG Pure Storage | $51.94 -1.2% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $45.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of Pure Storage (NYSE:PSTG) on 2/29/2024 |
RXST RxSight | $51.58 +1.8% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $40.00 -> $62.00 | Low | View details for JPMorgan Chase & Co. rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
CRM Salesforce | $301.18 -0.1% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $260.00 -> $310.00 | Low | View details for JPMorgan Chase & Co. rating of Salesforce (NYSE:CRM) on 2/29/2024 |
SILK Silk Road Medical | $18.32 -2.1% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $10.00 -> $19.00 | Low | View details for JPMorgan Chase & Co. rating of Silk Road Medical (NASDAQ:SILK) on 2/29/2024 |
PRKS United Parks & Resorts | $56.21 +5.4% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $57.00 -> $61.00 | Low | View details for JPMorgan Chase & Co. rating of United Parks & Resorts (NYSE:PRKS) on 2/29/2024 |
VCSA Vacasa | $6.82 -4.1% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $8.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Vacasa (NASDAQ:VCSA) on 2/29/2024 |
DV DoubleVerify | $35.15 +6.8% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $32.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of DoubleVerify (NYSE:DV) on 2/29/2024 |
ENLC EnLink Midstream | $13.64 +2.2% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $14.00 | Low | View details for JPMorgan Chase & Co. rating of EnLink Midstream (NYSE:ENLC) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $120.42 -0.1% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $180.00 -> $170.00 | Low | View details for JPMorgan Chase & Co. rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
GOGO Gogo | $8.78 +1.3% | 2/29/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $15.00 -> $11.00 | Low | View details for JPMorgan Chase & Co. rating of Gogo (NASDAQ:GOGO) on 2/29/2024 |
CWAN Clearwater Analytics | $17.69 +1.2% | 2/29/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $24.00 -> $22.00 | Low | View details for JPMorgan Chase & Co. rating of Clearwater Analytics (NYSE:CWAN) on 2/29/2024 |
AZO AutoZone | $3,152.07 -1.3% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $3,000.00 -> $3,200.00 | Low | View details for JPMorgan Chase & Co. rating of AutoZone (NYSE:AZO) on 2/28/2024 |
AXON Axon Enterprise | $312.88 -0.9% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $285.00 -> $330.00 | Low | View details for JPMorgan Chase & Co. rating of Axon Enterprise (NASDAQ:AXON) on 2/28/2024 |
FLYW Flywire | $24.81 +0.4% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $29.00 -> $32.00 | Low | View details for JPMorgan Chase & Co. rating of Flywire (NASDAQ:FLYW) on 2/28/2024 |
SJM J. M. Smucker | $125.83 +0.1% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $126.00 -> $128.00 | Low | View details for JPMorgan Chase & Co. rating of J. M. Smucker (NYSE:SJM) on 2/28/2024 |
TREE LendingTree | $42.34 +3.3% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $25.00 -> $38.00 | Low | View details for JPMorgan Chase & Co. rating of LendingTree (NASDAQ:TREE) on 2/28/2024 |
LNW Light & Wonder | $102.09 -1.8% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $98.00 -> $107.00 | Low | View details for JPMorgan Chase & Co. rating of Light & Wonder (NASDAQ:LNW) on 2/28/2024 |
LOW Lowe's Companies | $254.73 +0.6% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $265.00 -> $268.00 | Low | View details for JPMorgan Chase & Co. rating of Lowe’s Companies (NYSE:LOW) on 2/28/2024 |
MFIC MidCap Financial Investment | $15.04 +0.8% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $14.00 -> $14.50 | Low | View details for JPMorgan Chase & Co. rating of MidCap Financial Investment (NASDAQ:MFIC) on 2/28/2024 |
PRFT Perficient | $56.29 +3.4% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.00 -> $71.00 | Low | View details for JPMorgan Chase & Co. rating of Perficient (NASDAQ:PRFT) on 2/28/2024 |
PTGX Protagonist Therapeutics | $28.93 +1.6% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $34.00 -> $37.00 | Low | View details for JPMorgan Chase & Co. rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/28/2024 |
RYAN Ryan Specialty | $55.49 -0.4% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $44.00 -> $47.00 | Low | View details for JPMorgan Chase & Co. rating of Ryan Specialty (NYSE:RYAN) on 2/28/2024 |
ADNT Adient | $32.92 -0.8% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $41.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of Adient (NYSE:ADNT) on 2/28/2024 |
AMT American Tower | $197.59 +0.1% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $236.00 -> $230.00 | Low | View details for JPMorgan Chase & Co. rating of American Tower (NYSE:AMT) on 2/28/2024 |
ARRY Array Technologies | $14.91 -1.3% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $35.00 -> $29.00 | N/A | View details for JPMorgan Chase & Co. rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
BMBL Bumble | $11.35 +1.4% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
FSK FS KKR Capital | $19.07 +0.6% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $20.00 -> $18.00 | Low | View details for JPMorgan Chase & Co. rating of FS KKR Capital (NYSE:FSK) on 2/28/2024 |
PRGO Perrigo | $32.19 +2.3% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $48.00 -> $41.00 | Low | View details for JPMorgan Chase & Co. rating of Perrigo (NYSE:PRGO) on 2/28/2024 |
URBN Urban Outfitters | $43.42 +1.5% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $46.00 -> $44.00 | Low | View details for JPMorgan Chase & Co. rating of Urban Outfitters (NASDAQ:URBN) on 2/28/2024 |
APO Apollo Global Management | $112.45 -1.0% | 2/28/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $122.00 | Low | View details for JPMorgan Chase & Co. rating of Apollo Global Management (NYSE:APO) on 2/28/2024 |
IBP Installed Building Products | $258.50 +1.2% | 2/28/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $199.00 -> $242.00 | Low | View details for JPMorgan Chase & Co. rating of Installed Building Products (NYSE:IBP) on 2/28/2024 |
MELI MercadoLibre | $1,511.96 -0.7% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $2,000.00 -> $2,150.00 | Low | View details for JPMorgan Chase & Co. rating of MercadoLibre (NASDAQ:MELI) on 2/27/2024 |
TMDX TransMedics Group | $73.94 -0.2% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $87.00 -> $105.00 | Low | View details for JPMorgan Chase & Co. rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $46.69 -0.3% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $84.00 -> $88.00 | Low | View details for JPMorgan Chase & Co. rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
WYNN Wynn Resorts | $102.23 +0.4% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $118.00 -> $123.00 | Low | View details for JPMorgan Chase & Co. rating of Wynn Resorts (NASDAQ:WYNN) on 2/27/2024 |
ALLO Allogene Therapeutics | $4.47 +0.2% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $9.00 -> $8.00 | Low | View details for JPMorgan Chase & Co. rating of Allogene Therapeutics (NASDAQ:ALLO) on 2/27/2024 |